Academic Pediatrics
Volume 10, Issue 1 , Pages 36-40 , January 2010

Factors Associated with Detection and Receipt of Treatment for Youth with Depression and Anxiety Disorders

Received 27 February 2009 ,Accepted 15 September 2009.

References 

  1. Shaffer D, Fisher P, Dulcan MK, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry. 1996;35:865–877
  2. Costello EJ, Angold A, Burns BJ, et al. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry. 1996;53:1129–1136
  3. Leaf PJ, Alegria M, Cohen P, et al. Mental health service use in the community and schools: results from the four-community MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry. 1996;35:889–897
  4. Wu P, Hoven CW, Bird HR, et al. Depressive and disruptive disorders and mental health service utilization in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:1081–1090
  5. Cohen P, Kasen S, Brook JS, Struening EL. Diagnostic predictors of treatment patterns in a cohort of adolescents. J Am Acad Child Adolesc Psychiatry. 1991;30:989–993
  6. Angold A, Messer SC, Stangl D, et al. Perceived parental burden and service use for child and adolescent psychiatric disorders. Am J Public Health. 1998;88:75–80
  7. Wu P, Hoven CW, Cohen P, et al. Factors associated with use of mental health services for depression by children and adolescents. Psychiatr Serv. 2001;52:189–195
  8. Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med. 2002;156:592–598
  9. Libby AM, Brent DA, Morrato EH, et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007;164:884–891
  10. Nemeroff CB, Kalali A, Keller MB, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry. 2007;64:466–472
  11. Katon WJ, Richardson L, Russo J, et al. Quality of mental health care for youth with asthma and comorbid anxiety and depression. Med Care. 2006;44:1064–1072
  12. Katon W, Lozano P, Russo J, et al. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health. 2007;41:455–463
  13. Katon W, Russo J, Richardson L, et al. Anxiety and depression screening for youth in a primary care population. Ambul Pediatr. 2008;8:182–188
  14. Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev. 2000;21:265–271
  15. Shaffer D, Fisher P, Lucas CP, et al. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39:28–38
  16. Costello EJ, Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry. 1988;27:726–737
  17. Silverman W, Flergig W, Rabian B, et al. Childhood Anxiety Sensitivity Index. J Clin Child Psychol. 1995;20:162–168
  18. Bird HR, Canino G, Rubio-Stipec M, et al. Further measures of the psychometric properties of the children's global assessment scale (CGAS). Arch Gen Psychiatry. 1987;44:821–824
  19. Fishman PA, Shay DK. Development and estimation of a pediatric chronic disease score using automated pharmacy data. Med Care. 1999;37:874–883
  20. Burns BJ, Costello EJ, Angold A, et al. Children's mental health service use across service sectors. Health Aff (Millwood). 1995;14:147–159
  21. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299:901–913
  22. March J, Silva S, Vitiello B. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry. 2006;45:1393–1403
  23. Rushton JL, Felt BT, Roberts MW. Coding of pediatric behavioral and mental disorders. Pediatrics. 2002;110:e8

PII: S1876-2859(09)00259-9

doi: 10.1016/j.acap.2009.09.011

Academic Pediatrics
Volume 10, Issue 1 , Pages 36-40 , January 2010

Article Tools

* Image Usage & Resolution